Tocagen Inc. Email Format

BiotechnologyCalifornia, United States51-200 Employees

Tocagen Inc. is a biotechnology research company based in San Diego, California, founded in 2007 with a focus on cancer treatment. Its work centers on developing cancer-selective gene therapies that aim to empower a patient’s own immune system to attack tumors, using a retroviral replicating vector platform to deliver therapeutic genes directly into cancer cell DNA. The approach seeks to combine multiple mechanisms of action while aiming to reduce harm to healthy tissue, potentially offering an option alongside existing cancer therapies. The company positions itself as pursuing a broader application of gene therapy to address various forms of cancer, including advanced local and metastatic disease.

Tocagen targets patients with cancer, particularly those with limited treatment options, such as recurrent high-grade glioma, and emphasizes therapies designed to activate immune responses from within the tumor environment. It operates within the biotechnology research industry, developing its platform and product candidates to potentially extend patient lifespan. The company’s location in San Diego situates it in a region known for biotech research, and its history reflects ongoing clinical development and leadership changes relevant to advancing its investigational programs.

Get verified Tocagen Inc. emails free

Company overview Employee directory